logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

KUAISHOU-W (01024) granted a total of 9.79433 million restricted share units.

date
20:11 20/01/2025
avatar
GMT Eight
-W (01024) announced that on January 20, 2025, the company will issue a certain number of shares to eligible participants in accordance with the...
KUAISHOU-W (01024) announced that on January 20, 2025, the company granted a total of 9.79433 million restricted stock units to eligible participants under the 2023 share incentive plan, but they must be accepted by the grantees before they can become effective.
Related Articles
China Stock
Innovative Medical Management (002173.SZ) affiliated company Quan Zhen Medical plans to advance Series B financing.
China Stock
Tianjin Lisheng Pharmaceutical (002393.SZ): The application for the listing permit of Apimist tablets has been approved.
New Stock News | HASHKEY HLDGS (03887) the public offering has ended with total subscriptions of 50.6 billion Hong Kong dollars, oversubscribed by 301.6 times.
Innovative Medical Management (002173.SZ) affiliated company Quan Zhen Medical plans to advance Series B financing.
China Stock
Tianjin Lisheng Pharmaceutical (002393.SZ): The application for the listing permit of Apimist tablets has been approved.
China Stock
New Stock News | HASHKEY HLDGS (03887) the public offering has ended with total subscriptions of 50.6 billion Hong Kong dollars, oversubscribed by 301.6 times.
RECOMMEND
Year‑End Sprint, Chinese And American Tech Giants Intensify Competition
Year‑End Sprint, Chinese And American Tech Giants Intensify Competition
icon
12/12/2025
Positive Signal! Hong Kong Stocks See New Wave Of Buybacks Led By Major Technology Firms
Positive Signal! Hong Kong Stocks See New Wave Of Buybacks Led By Major Technology Firms
icon
12/12/2025
Federal Reserve Chair Powell Speaks On Interest Rate Cut Decision
Federal Reserve Chair Powell Speaks On Interest Rate Cut Decision
icon
12/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.